Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 41

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT01238575Phase 4Completed
Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder
Pervasive Development Disorders
Principalinvestigator
NCT01894958Phase 2Completed
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
Fragile X Syndrome
Principalinvestigator

Research Network

Collaboration Network

33 collaborators·66 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Seattle Children's Hospital

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

James McCracken, MD

University of California, Los Angeles

Related
8 trials

Shared therapeutic areas:

Fragile X SyndromePervasive Development Disorders

Worked with same sponsors:

Emory UniversityMassachusetts General Hospital+4 more
Collaborated on 1 trial
Similarity Score24%

Janet E Hall, M.D.

Massachusetts General Hospital

Related
7 trials

Shared therapeutic areas:

Fragile X Syndrome

Worked with same sponsors:

Massachusetts General Hospital
Similarity Score15%

Ginger Nicol, MD

Washington University School of Medicine

Related
7 trials

Shared therapeutic areas:

Pervasive Development Disorders

Worked with same sponsors:

National Institute of Mental Health (NIMH)
Similarity Score15%

Lawrence Ginsberg, MD

Red Oaks Psychiatry Associates, PA

Related
4 trials

Shared therapeutic areas:

Fragile X Syndrome
Similarity Score15%

Jeremy Veenstra-VanderWeele, MD

Vanderbilt Kennedy Center

Related
4 trials

Shared therapeutic areas:

Fragile X Syndrome
Similarity Score15%

Elizabeth Berry-Kravis, MD, PhD

Rush University Medical Center

Related
5 trials

Shared therapeutic areas:

Fragile X Syndrome
Similarity Score15%

Linmarie Sikich, MD

University of North Carolina Neurosciences Hospital

Related
4 trials

Shared therapeutic areas:

Fragile X Syndrome
Similarity Score15%

David Crowley, MD

KGK Science Inc.

Related
54 trials

Shared therapeutic areas:

Fragile X Syndrome
Similarity Score15%

Bryan King, MD, PhD

Seattle Children's Hospital

Related
4 trials

Shared therapeutic areas:

Fragile X Syndrome
Similarity Score15%

Robert B Innis, M.D.

National Institute of Mental Health (NIMH)

Related
35 trials

Shared therapeutic areas:

Fragile X Syndrome

Worked with same sponsors:

National Institute of Mental Health (NIMH)
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT01238575Phase 4PrincipalInvestigator

Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder

Pervasive Development Disorders
Completed
NCT01894958Phase 2PrincipalInvestigator

A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome

Fragile X Syndrome
Completed

All 2 trials loaded